Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
2019-01-01 Conforti, F.; Pala, L.; Bagnardi, V.; Viale, G.; De Pas, T.; Pagan, E.; Pennacchioli, E.; Cocorocchio, E.; Ferrucci, P. F.; De Marinis, F.; Gelber, R. D.; Goldhirsch, A.
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy
2022-01-01 Corti, C; Conforti, F; Pala, L; Catania, C; Cocorocchio, E; Ferrucci, Pf; Curigliano, G; Queirolo, P; De Pas, T
Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to action
2022-01-01 Pala, L; De Pas, T; Conforti, F
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center
2024-01-01 Valenza, Carmine; De Pas, Tommaso Martino; Gaeta, Aurora; Castellano, Grazia; Santoro, Celeste; Corona, Amedeo; Chiappini, Giulia; Vivanet, Grazia; Trapani, Dario; Coppola, Sara; Conforti, Fabio; Mattar, Denise; Gandini, Sara; Veronesi, Paolo; Pennacchioli, Elisabetta; Curigliano, Giuseppe
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
2018-01-01 Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Martinetti, M; Viale, G; Gelber, Rd; Goldhirsch, A
Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors
2020-01-01 Cocorocchio, E; Martinoli, C; Gandini, S; Pala, L; Conforti, F; Stucchi, S; Mazzarol, G; Ferrucci, P
High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study
2023-01-01 Conforti, F; Pala, L; Vivanet, G; Corti, C; Catania, C; Maiettini, D; Varano, G; Di Venosa, B; Curigliano, G; Salvini, P; Berardi, R; Ballatore, Z; De Pas, Tm
Molecular Pathways: Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling
2015-01-01 Conforti, F; Wang, Ys; Rodriguez, Ja; Alberobello, At; Zhang, Yw; Giaccone, G
Sex and cancer immunotherapy: Current understanding and challenges
2022-01-01 Pala, Laura; De Pas, Tommaso; Catania, Chiara; Giaccone, Giuseppe; Mantovani, Alberto; Minucci, Saverio; Viale, Giuseppe; Gelber, Richard D; Conforti, Fabio
Gender-Based Differences in the Efficacy of Anti-EGFR/BRAF/MEK Targeted Therapy in Patients with BRAF-Mutated Metastatic Colorectal Cancer
2025-01-01 Pala, Laura; De Pas, Tommaso; Cocorocchio, Emilia; Catania, Chiara; Ceresoli, Giovanni; Laszlo, Daniele; Zattarin, Emma; Rossi, Giovanna; Conforti, Fabio
A phase II study of regorafenib in patients with thymic epithelial tumours previously treated with chemotherapy
2018-01-01 Perrino, M; Bozzarelli, S; Zucali, Pa; De Pas, Tm; Simonelli, M; De Vincenzo, F; Conforti, F; Persico, P; Miggiano, C; Cordua, N; Cioffi, A; Sala, S; Sposta, Fm; Giordano, L; Santoro, A
Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E
2014-01-01 Catania, C; Conforti, F; Spitaleri, G; Barberis, M; Preda, L; Noberasco, C; Lazzari, C; Toffalorio, F; De Marinis, F; Manzotti, M; De Pas, Tm
Sex as a predictor of response to cancer immunotherapy Reply
2018-01-01 Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Marco, M; Viale, G; Gelber, R; Goldhirsch, A
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review
2023-01-01 Digiacomo, N; De Pas, T; Rossi, G; Bossi, P; Stucchi, E; Conforti, F; Cocorocchio, E; Laszlo, D; Pala, L; Zattarin, E; Catania, C
Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome
2021-01-01 Cocorocchio, E; Nezi, L; Gandini, S; Manzo, T; Mazzarella, L; Lotti, F; Pala, L; Gnagnarella, P; Conforti, F; Pennacchioli, E; Fierro, Mt; Ribero, S; Senetta, R; Picciotto, F; Caliendo, V; Quaglino, P; Mazzarol, G; Orsolini, Gm; Prestianni, P; Ferrucci, Pf
Thymic epithelial tumors: From biology to treatment
2020-01-01 Conforti, F; Pala, L; Giaccone, G; De Pas, T
EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung
2013-01-01 Conforti, F; Catania, C; Toffalorio, F; Duca, M; Spitaleri, G; Barberis, M; Noberasco, C; Delmonte, A; Santarpia, M; Lazzari, C; De Pas, Tm
Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative Tumors
2019-01-01 Conforti, F; Pala, L
The effect of patient sex on the efficacy and safety of anticancer immunotherapy
2021-01-01 Pala, L; Conforti, F
Successful treatment with avapritinib in patient with mucosal metastatic melanoma
2020-01-01 Cocorocchio, E; Pala, L; Conforti, F; Guerini-Rocco, E; De Pas, T; Ferrucci, Pf
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis | 1-gen-2019 | Conforti, F.; Pala, L.; Bagnardi, V.; Viale, G.; De Pas, T.; Pagan, E.; Pennacchioli, E.; Cocorocchio, E.; Ferrucci, P. F.; De Marinis, F.; Gelber, R. D.; Goldhirsch, A. | |
| Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy | 1-gen-2022 | Corti, C; Conforti, F; Pala, L; Catania, C; Cocorocchio, E; Ferrucci, Pf; Curigliano, G; Queirolo, P; De Pas, T | |
| Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to action | 1-gen-2022 | Pala, L; De Pas, T; Conforti, F | |
| Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center | 1-gen-2024 | Valenza, Carmine; De Pas, Tommaso Martino; Gaeta, Aurora; Castellano, Grazia; Santoro, Celeste; Corona, Amedeo; Chiappini, Giulia; Vivanet, Grazia; Trapani, Dario; Coppola, Sara; Conforti, Fabio; Mattar, Denise; Gandini, Sara; Veronesi, Paolo; Pennacchioli, Elisabetta; Curigliano, Giuseppe | |
| Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis | 1-gen-2018 | Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Martinetti, M; Viale, G; Gelber, Rd; Goldhirsch, A | |
| Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors | 1-gen-2020 | Cocorocchio, E; Martinoli, C; Gandini, S; Pala, L; Conforti, F; Stucchi, S; Mazzarol, G; Ferrucci, P | |
| High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study | 1-gen-2023 | Conforti, F; Pala, L; Vivanet, G; Corti, C; Catania, C; Maiettini, D; Varano, G; Di Venosa, B; Curigliano, G; Salvini, P; Berardi, R; Ballatore, Z; De Pas, Tm | |
| Molecular Pathways: Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling | 1-gen-2015 | Conforti, F; Wang, Ys; Rodriguez, Ja; Alberobello, At; Zhang, Yw; Giaccone, G | |
| Sex and cancer immunotherapy: Current understanding and challenges | 1-gen-2022 | Pala, Laura; De Pas, Tommaso; Catania, Chiara; Giaccone, Giuseppe; Mantovani, Alberto; Minucci, Saverio; Viale, Giuseppe; Gelber, Richard D; Conforti, Fabio | |
| Gender-Based Differences in the Efficacy of Anti-EGFR/BRAF/MEK Targeted Therapy in Patients with BRAF-Mutated Metastatic Colorectal Cancer | 1-gen-2025 | Pala, Laura; De Pas, Tommaso; Cocorocchio, Emilia; Catania, Chiara; Ceresoli, Giovanni; Laszlo, Daniele; Zattarin, Emma; Rossi, Giovanna; Conforti, Fabio | |
| A phase II study of regorafenib in patients with thymic epithelial tumours previously treated with chemotherapy | 1-gen-2018 | Perrino, M; Bozzarelli, S; Zucali, Pa; De Pas, Tm; Simonelli, M; De Vincenzo, F; Conforti, F; Persico, P; Miggiano, C; Cordua, N; Cioffi, A; Sala, S; Sposta, Fm; Giordano, L; Santoro, A | |
| Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E | 1-gen-2014 | Catania, C; Conforti, F; Spitaleri, G; Barberis, M; Preda, L; Noberasco, C; Lazzari, C; Toffalorio, F; De Marinis, F; Manzotti, M; De Pas, Tm | |
| Sex as a predictor of response to cancer immunotherapy Reply | 1-gen-2018 | Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Marco, M; Viale, G; Gelber, R; Goldhirsch, A | |
| Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review | 1-gen-2023 | Digiacomo, N; De Pas, T; Rossi, G; Bossi, P; Stucchi, E; Conforti, F; Cocorocchio, E; Laszlo, D; Pala, L; Zattarin, E; Catania, C | |
| Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome | 1-gen-2021 | Cocorocchio, E; Nezi, L; Gandini, S; Manzo, T; Mazzarella, L; Lotti, F; Pala, L; Gnagnarella, P; Conforti, F; Pennacchioli, E; Fierro, Mt; Ribero, S; Senetta, R; Picciotto, F; Caliendo, V; Quaglino, P; Mazzarol, G; Orsolini, Gm; Prestianni, P; Ferrucci, Pf | |
| Thymic epithelial tumors: From biology to treatment | 1-gen-2020 | Conforti, F; Pala, L; Giaccone, G; De Pas, T | |
| EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung | 1-gen-2013 | Conforti, F; Catania, C; Toffalorio, F; Duca, M; Spitaleri, G; Barberis, M; Noberasco, C; Delmonte, A; Santarpia, M; Lazzari, C; De Pas, Tm | |
| Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative Tumors | 1-gen-2019 | Conforti, F; Pala, L | |
| The effect of patient sex on the efficacy and safety of anticancer immunotherapy | 1-gen-2021 | Pala, L; Conforti, F | |
| Successful treatment with avapritinib in patient with mucosal metastatic melanoma | 1-gen-2020 | Cocorocchio, E; Pala, L; Conforti, F; Guerini-Rocco, E; De Pas, T; Ferrucci, Pf |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista27913
Data di pubblicazione
- In corso di stampa14
- 2020 - 20269648
- 2010 - 201911835
- 2000 - 20094579
- 1990 - 19991485
- 1980 - 1989329
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE372
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...267
- ANNALS OF ONCOLOGY244
- CANCERS232
- PLOS ONE223
- THE JOURNAL OF NUCLEAR MEDICINE222
- JOURNAL OF CLINICAL MEDICINE215
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY197
- ALLERGY180
Keyword
- Humans2166
- Female1035
- Male996
- Middle Aged767
- Aged669
- Adult559
- COVID-19441
- Treatment Outcome373
- Animals329
- Retrospective Studies264
Lingua
- eng19967
- ita459
- spa14
- fre11
- ger8
- enm4
- por2
- chi1
Accesso al fulltext
- no fulltext25660
- reserved1362
- open891